GlassScriptPhysician profile
Scott A Timmer
NPI 1881073427
$418.94
in general payments reported to CMS, 2019-2025
9 companies · $83.34 in 2025
The $83.34 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.76 · 2020: $40.37 · 2021: $134 · 2022: $71.83 · 2023: $19.54 · 2024: $23.85 · 2025: $83.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $122.76 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $85.11 | 2020-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.80 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $42.61 | 2021-2025 | Zerbaxa |
| Abbvie INC. | $34.84 | 2021 | |
| Vyera Pharmaceuticals, LLC | $17.88 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.80 | 2025 | Lifevest |
| Novo Nordisk INC | $15.13 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Timmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.